Emcure Pharmaceuticals consolidated net profit rises 49.97% in the December 2025 quarter
Sales rise 20.42% to Rs 2363.48 crore
Net profit of Emcure Pharmaceuticals rose 49.97% to Rs 230.54 crore in the quarter ended December 2025 as against Rs 153.72 crore during the previous quarter ended December 2024. Sales rose 20.42% to Rs 2363.48 crore in the quarter ended December 2025 as against Rs 1962.63 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales2363.481962.63 20 OPM %20.8518.07 -PBDT456.62326.73 40 PBT351.94229.92 53 NP230.54153.72 50Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 04 2026 | 5:17 PM IST